Altamira Therapeutics Overview
Altamira Therapeutics Discounted Cash Flow
DCF Analysis for CYTO.
Get informed when a big investor buys or sells
+ FollowFair Value
$1.18
Current Fair Value
$1.18
↑ 293.6% Upside
Undervalued by 293.6% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison